We have located links that may give you full text access.
β 2 -adrenoceptors indirectly support impaired β 1 -adrenoceptor responsiveness in the isolated type 2 diabetic rat heart.
Experimental Physiology 2019 March 20
NEW FINDINGS: What is the central question of this study? Are there specific contributions of β1 - and β2 -adrenoceptor subtypes to the impaired β-adrenoceptor responsiveness of the type 2 diabetic heart. What is the main finding and its importance? In hearts, isolated from the Zucker Diabetic Fatty rat model of type 2 diabetes, we showed that the β1 - adrenoceptors are the main subtype to regulate heart rate, contraction and relaxation. Notably, the β2 - adrenoceptor subtype actions seem to indirectly support function in the diabetic heart.
ABSTRACT: Impaired β-adrenoceptor (β-AR) responsiveness causes cardiac vulnerability in patients with type 2 diabetes, however the independent contributions of β1 - and β2 -AR subtypes to β-AR-associated cardiac dysfunction in diabetes are unknown. Our aim was to determine the specific β1 - and β2 -AR responsiveness of heart rate (HR), contraction and relaxation in the diabetic heart. Isolated Langendorff-perfused hearts of Zucker type 2 Diabetic Fatty (ZDF) rats were stimulated with the β-AR agonist isoproterenol (1 × 10-11 -3 × 10-8 mol L-1 ) with or without selective β1 -AR antagonist CGP20712A (3 × 10-8 mol L-1 ) or β2 -AR antagonist ICI-118,551 (5 × 10-8 mol L-1 ); and HR, contraction and relaxation were measured. Diabetic hearts showed lower basal HR (non-diabetic 216 ± 17 vs. diabetic 151 ± 23 bpm, p < 0.05). However, the β-AR-induced increase in HR was similar, and was completely blocked by the β1 -AR antagonist, but not by the β2 -AR antagonist. The β-AR-induced increase in contraction and acceleration of relaxation was impaired in diabetic hearts, completely blocked by β1 -AR antagonist, and partially impaired by β2 -AR antagonist. Western blots revealed 41% higher phosphorylation levels of AMP kinase (AMPK), a key regulator of cardiac energy metabolism, in diabetic hearts (non-diabetic 1.62 ± 0.19 vs. diabetic 2.30 ± 0.25 arbitrary units, p < 0.05). In conclusion, the β1 -AR is the main subtype regulating chronotropic, inotropic and lusitropic β-AR responses in the healthy, as well as the type 2 diabetic, heart. The β2 -AR subtype indirectly, supports the β1 -AR functional response in the diabetic heart. This suggests β2 -ARs could be an indirect target to improve the function of the heart under type 2 diabetic conditions. This article is protected by copyright. All rights reserved.
ABSTRACT: Impaired β-adrenoceptor (β-AR) responsiveness causes cardiac vulnerability in patients with type 2 diabetes, however the independent contributions of β1 - and β2 -AR subtypes to β-AR-associated cardiac dysfunction in diabetes are unknown. Our aim was to determine the specific β1 - and β2 -AR responsiveness of heart rate (HR), contraction and relaxation in the diabetic heart. Isolated Langendorff-perfused hearts of Zucker type 2 Diabetic Fatty (ZDF) rats were stimulated with the β-AR agonist isoproterenol (1 × 10-11 -3 × 10-8 mol L-1 ) with or without selective β1 -AR antagonist CGP20712A (3 × 10-8 mol L-1 ) or β2 -AR antagonist ICI-118,551 (5 × 10-8 mol L-1 ); and HR, contraction and relaxation were measured. Diabetic hearts showed lower basal HR (non-diabetic 216 ± 17 vs. diabetic 151 ± 23 bpm, p < 0.05). However, the β-AR-induced increase in HR was similar, and was completely blocked by the β1 -AR antagonist, but not by the β2 -AR antagonist. The β-AR-induced increase in contraction and acceleration of relaxation was impaired in diabetic hearts, completely blocked by β1 -AR antagonist, and partially impaired by β2 -AR antagonist. Western blots revealed 41% higher phosphorylation levels of AMP kinase (AMPK), a key regulator of cardiac energy metabolism, in diabetic hearts (non-diabetic 1.62 ± 0.19 vs. diabetic 2.30 ± 0.25 arbitrary units, p < 0.05). In conclusion, the β1 -AR is the main subtype regulating chronotropic, inotropic and lusitropic β-AR responses in the healthy, as well as the type 2 diabetic, heart. The β2 -AR subtype indirectly, supports the β1 -AR functional response in the diabetic heart. This suggests β2 -ARs could be an indirect target to improve the function of the heart under type 2 diabetic conditions. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app